Wyszukaj lek sierocy
Inne opcje wyszukiwania
33 Wyniki
Substancja (substancje)
- 3-{[2,3,5,6-tetrafluoro-3'-(trifluoromethoxy)biphenyl-4-yl]carbamoyl}thiophene-2-carboxylic acid
- 4-((E)-(5-(2-(2-((S)-2-((S)-1-(L-threonyl-L-lysyl)pyrrolidine-2-carboxamido)-5-guanidinopentanamido)acetamido)-2-carboxyethyl)-2-hydroxyphenyl)diazenyl)phenyl (2-(trimethylammonio)ethyl) phosphate
- AAV2.adalimumab
- Adalimumab
- Autologous collagen type II-specific regulatory T cells
- Cyclo {{(E,Z)-(2S,3R,4R)-3-hydroxy-4-methyl-2-(methylamino)nona-6,8-dienoyl}-L-2-aminobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanyl-Dalanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl}
- DNA plasmid encoding a recombinant fusion protein consisting of the extracellular domain of human TNFalpha p55 receptor linked to the human IgG1 Fc domain
- Dexamethasone (intravitreal implant)
- Difluprednate
- E. Coli heat-shock protein 70 with bovine retinal S-antigen
- Fluocinolone
- Fluocinolone acetonide (prolonged-release intravitreal implant)
- Gevokizumab
- HLA-B27 derived peptide (amino acid 125-138)
- Recombinant human monoclonal antibody to human Interleukin (IL)-17A of the IgG1/k class
- Sirolimus
- Triamcinolone
- Voclosporin